Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clascoterone solution in male androgenetic alopecia
NCT05914805Phase 3Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of clascoterone in androgenetic alopecia (AGA), sponsored by Cassiopea S.p.A.. Started Aug 2023; status: completed.
02
Drugs
clascoterone
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05914805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914805.